Wei Cheng
Managing Director @ TF Capital
Boston, United States
Wei Cheng is a managing director of TF Capita.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Wei Cheng invests in
Stages Wei Cheng invests in
Countries Wei Cheng invests in
Investment Focus
Industry
- Medical 1 (100%)
- Therapeutics 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses. Allorion operates two locations in Natick, Massachusetts, and Guangzhou, China. | $50M / Series B / Mar 09, 2023 |
Co-Investors
About TF Capital
TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.
TF Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Dr. Zhang Yibo
Partner
|
|||
|
H.J. Jiang
Founder & CEO
|
|||
|
Wei Cheng
Managing Director
|
|||
|
Yi Liu
Director
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Wei Cheng invest in?
Wei Cheng invests primarily in Medical, Therapeutics and Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Wei Cheng last invest?
The most recent investment recorded for Wei Cheng closed in Mar 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!